BDBM50307959 4-(4-Chlorobenzyl)-1-(1H-pyrrolo[2,3-b]pyridin-4-yl)piperidin-4-amine::CHEMBL596991::US8796293, 54
SMILES: NC1(Cc2ccc(Cl)cc2)CCN(CC1)c1ccnc2[nH]ccc12
InChI Key: InChIKey=KOBAABHHGSLFGF-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase AKT2 (Homo sapiens (Human)) | BDBM50307959 (4-(4-Chlorobenzyl)-1-(1H-pyrrolo[2,3-b]pyridin-4-y...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Institute of Cancer Research Curated by ChEMBL | Assay Description Inhibition of PKBbeta by radiometric filter binding assay | J Med Chem 53: 2239-49 (2010) Article DOI: 10.1021/jm901788j BindingDB Entry DOI: 10.7270/Q23B608V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Rho-associated protein kinase 2 (Homo sapiens (Human)) | BDBM50307959 (4-(4-Chlorobenzyl)-1-(1H-pyrrolo[2,3-b]pyridin-4-y...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | <10 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Astex Therapeutics Limited; The Institute of Cancer Research: Royal Cancer Hospital; Cancer Research Technology Limited US Patent | Assay Description In a final reaction volume of 25 ul, ROCK-II (h) (5-10 mU) is incubated with 50 mM Tris pH 7.5, 0.1 mM EGTA, 30 uM KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK (... | US Patent US8796293 (2014) BindingDB Entry DOI: 10.7270/Q21C1VJM | |||||||||||
More data for this Ligand-Target Pair |